Autophagy-Dependent Mechanisms |
CR stimulates autophagy, promoting ATP secretion and facilitating DC recruitment, a crucial step in mediating an adaptive antitumor immune response. This effect is particularly potent when combined with therapeutic regimens that induce immunogenic cell death. |
[89–92] |
Inhibition of Tumor Growth |
Fasting and CR synergize with tyrosine kinase inhibitors, including crizotinib, in inhibiting tumor growth. Fasting also improves the response to radio- and chemotherapy in mouse glioma models. |
[91–93] |
Enhanced T-Cell Activity |
Energy reduction interventions enhance CD8 + T cell infiltration into the tumor bed while concurrently reducing regulatory CD4 + T lymphocytes. |
[93] |
Enhancement of Myeloid Cells and DCs: |
Energy reduction can enrich mature monocyte-derived DCs, involving critical CD11b+ myeloid cells. |
[94] |
Sensitization to Immunotherapy |
CR, through various mechanisms, can enhance cancer cell sensitivity to T-cell-mediated killing, supporting the idea of combining CR with immunotherapy. |
[95, 96] |
Combinatorial Strategies |
Combining caloric restriction mimetics with ICD-inducing chemotherapy and ICIs improves therapeutic outcomes in preclinical studies. |
[94] |